Sugi Predict

Sugi Predict / Compounds / SCHEMBL29437929

SCHEMBL29437929

SCHEMBL29437929

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 5/20 0.55
▸ CALCRL Q16602 2/20 0.53
▸ F2 P00734 4/20 0.51
▸ CALCR P30988 4/20 0.51
▸ SLC6A2 P23975 1/20 0.49
▸ AGTR1 P30556 1/20 0.49
▸ AGTR2 P50052 1/20 0.49
▸ NMBR P28336 1/20 0.48
▸ GRPR P30550 1/20 0.48
▸ APLNR P35414 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477486 1.00 REN (0.55) RENCALCRLF2CALCRSLC6A2
SCHEMBL30477485 1.00 REN (0.55) RENCALCRLF2CALCRSLC6A2
SCHEMBL30512510 0.86 CALCR (0.51) RENF2CALCRAPLNR
SCHEMBL29798291 0.86 CALCR (0.54) CALCRLF2CALCRNMBRGRPR
SCHEMBL30692437 0.86 REN (0.51) RENCALCRLF2SLC6A2
SCHEMBL31437675 0.86 REN (0.53) RENCALCRLF2CALCRSLC6A2
SCHEMBL29448209 0.85 REN (0.66) RENAGTR1AGTR2
SCHEMBL6516908 0.85 REN (0.58) RENSLC6A2
SCHEMBL29525618 0.85 REN (0.58) RENSLC6A2
SCHEMBL30676223 0.85 REN (0.47) RENF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US claimed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN claimed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO claimed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO claimed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
Send feedback